Tag: Luminar Technologies

MemryX Appoints Ross Jatou as CEO and Joe Faris as VP of Sales and Marketing to Accelerate AI Infrastructure Expansion

Industry veterans join as MemryX expands its production-proven AI architecture from edge deployments into the data centerANN ARBOR, Mich., June 2, 2026 /PRNewswire/ --...

LightPath Technologies Appoints Respected Photonics Veteran Stephen Mielke, Ph.D., as Vice President of Engineering

Former Luminar Optical Engineering Executive to Spearhead LightPath's Transition from Component to System Supplier ORLANDO, Fla., Aug. 12, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LAZR

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LAZR

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline.

LAZR Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Luminar Technologies, Inc.

Robbins LLP is Investigating Allegations that Luminar Technologies, Inc. (LAZR) Failed to Disclose that its President and CEO was Engaged in Misconduct

Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc....

PHILADELPHIA, July 27, 2025 (GLOBE NEWSWIRE) --

Alto Neuroscience, Inc. (NYSE: ANRO):

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Luminar Technologies, Inc. – LAZR

NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Luminar Technologies, Inc. ("Luminar" or the "Company")...

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

El evento promocional «Oportunidad en China: Jinan, la ciudad de los manantiales» tuvo lugar en Madrid

Anime “KAGURABACHI” Unveils Chihiro Rokuhira Character Visual & Character Trailer

Tag: Luminar Technologies

MemryX Appoints Ross Jatou as CEO and Joe Faris as VP of Sales and Marketing to Accelerate AI Infrastructure Expansion

LightPath Technologies Appoints Respected Photonics Veteran Stephen Mielke, Ph.D., as Vice President of Engineering

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LAZR

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LAZR

LAZR Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Luminar Technologies, Inc.

Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc....

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Luminar Technologies, Inc. – LAZR

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us